MEDP

Medpace Holdings

527.93

-9.80-1.82%

After Hours: 527.93 0.00 0.00%19:34 07/20 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE537.35/537.73

TODAY RANGE526.93-539.80

VOL283.51K

MARKET CAP15.08B

52 WEEK RANGE306.70-628.92

AVG VOL (3M)362.40K

% TURNOVER0.99%

TURNOVER--

P/E (TTM)33.22

% RANGE2.39%

EPS(TTM)15.89

P/E(FORWARD)31.14

P/B25.14

BVPS21.00

DIVIDEND--

P/S5.91

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP12.15B

SHARES OUTSTANDING28.56M

NEXT EARNINGS07/20-07/24

FREE FLOAT23.01M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·6d ago
Medpace Backs Phase 2 Cancer Imaging Trial With [68Ga]BED003
NASDAQ·07/13 22:15
Why Medpace (MEDP) Dipped More Than Broader Market Today
TipRanks·07/13 11:45
Medpace price target raised to $586 from $495 at Mizuho
Dow Jones·07/13 11:07
Medpace Holdings Is Maintained at Outperform by Mizuho
Dow Jones·07/13 11:07
Medpace Holdings Price Target Raised to $586.00/Share From $495.00 by Mizuho
Reuters·07/13 10:43
MEDPACE HOLDINGS INC <MEDP.O>: MIZUHO RAISES TARGET PRICE TO $586 FROM $495
Reuters·07/09 10:51
BUZZ-TD Cowen sees improving demand for contract research firms in Q2 2026
TipRanks·07/08 13:40
Dollar Tree upgraded, PayPal initiated: Wall Street’s top analyst calls
Dow Jones·07/08 09:46
Medpace Holdings Price Target Raised to $547.00/Share From $477.00 by Baird
Dow Jones·07/08 09:46
Medpace Holdings Cut to Neutral From Outperform by Baird
TipRanks·07/08 09:30
Medpace downgraded to Neutral from Outperform at Baird
NASDAQ·07/07 13:52
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026
TipRanks·07/07 13:40
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
Dow Jones·07/07 09:59
Medpace Holdings Cut to Hold From Buy by Jefferies
Dow Jones·07/07 09:59
Medpace Holdings Price Target Raised to $515.00/Share From $490.00 by Jefferies

Same Industry

Name/Symbol

Change%

Price

Medpace Holdings

MEDP

-1.82%

527.93

REGN

GridAI Tech

GRDX

+0.26%

3.820

BNTX

United Therapeutics Corp.

UTHR

+1.25%

535.67

Vertex Pharmaceuticals Inc

VRTX

-0.08%

485.65

Siga Technologie

SIGA

-3.37%

3.440

MRNA

Charles Riv Labs Intl Inc

CRL

-2.07%

219.70

TLPH

CBPO

ICLR

Iqvia Hldgs Inc

IQV

-1.14%

203.90

MOLN

Arcturus Therape

ARCT

-2.10%

6.05

PRAH

Gilead Sciences Inc

GILD

-1.48%

134.28

Incyte Corp

INCY

+0.51%

117.25

APVO

BSTC

Kiniksa Pharmaceuticals International, plc

KNSA

+4.65%

63.95

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.